These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26896598)

  • 1. ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.
    Shang S; Qin X; Li W; Zhang S; Liu Y
    Discov Med; 2016 Jan; 21(113):15-23. PubMed ID: 26896598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid diagnosis of hepatocellular carcinoma using a haptoglobin ELISA assay based on AAL-coated magnetic beads.
    Shang S; Sun L; Li W; Qin X; Zhang S; Liu Y
    Discov Med; 2016 Sep; 22(120):97-104. PubMed ID: 27755965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
    Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
    Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
    Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
    Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases.
    Jiang K; Shang S; Li W; Guo K; Qin X; Zhang S; Liu Y
    Glycoconj J; 2015 Dec; 32(9):657-64. PubMed ID: 26342810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
    Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
    Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of AFP-negative early-stage hepatocellular carcinoma using Fuc-PON1.
    Shu H; Li W; Shang S; Qin X; Zhang S; Liu Y
    Discov Med; 2017 Mar; 23(126):163-168. PubMed ID: 28472609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse lectin ELISA for detecting fucosylated forms of α1-acid glycoprotein associated with hepatocellular carcinoma.
    Åström E; Stål P; Zenlander R; Edenvik P; Alexandersson C; Haglund M; Rydén I; Påhlsson P
    PLoS One; 2017; 12(3):e0173897. PubMed ID: 28296934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.
    Shimomura M; Nakayama K; Azuma K; Terao N; Nishino K; Takamatsu S; Nakano M; Takahashi S; Kobayashi Y; Murata K; Kamada Y; Miyoshi E
    Clin Chim Acta; 2015 Jun; 446():30-6. PubMed ID: 25861849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.
    Matsumoto H; Shinzaki S; Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Kanke F; Satomura S; Kumada T; Miyoshi E
    Clin Chem Lab Med; 2010 Apr; 48(4):505-12. PubMed ID: 20128732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
    Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
    J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios.
    Shang S; Li W; Qin X; Zhang S; Liu Y
    J Cancer; 2017; 8(5):887-893. PubMed ID: 28382152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of fucosylated GP73 in the differential diagnosis of hepatocellular carcinoma.
    Zhao Y; Zhang L; Huo L; Pei L; Li Q; Li H; Jin L
    Int J Biol Markers; 2018 Nov; 33(4):439-446. PubMed ID: 30238841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
    Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of Pholiota squarrosa lectin-reactive haptoglobin as a pancreatic cancer biomarker using an improved ELISA system.
    Kusama K; Okamoto Y; Saito K; Kasahara T; Murata T; Ueno Y; Kobayashi Y; Kamada Y; Miyoshi E
    Glycoconj J; 2017 Aug; 34(4):537-544. PubMed ID: 28455724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions.
    Kamada Y; Kinoshita N; Tsuchiya Y; Kobayashi K; Fujii H; Terao N; Kamihagi K; Koyama N; Yamada S; Daigo Y; Nakamura Y; Taniguchi N; Miyoshi E
    Clin Chim Acta; 2013 Feb; 417():48-53. PubMed ID: 23262369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases.
    Li L; Gu X; Fang M; Ji J; Yi C; Gao C
    Clin Chem Lab Med; 2016 Apr; 54(4):693-701. PubMed ID: 26035113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
    Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
    Tawara S; Tatsumi T; Iio S; Kobayashi I; Shigekawa M; Hikita H; Sakamori R; Hiramatsu N; Miyoshi E; Takehara T
    PLoS One; 2016; 11(3):e0151828. PubMed ID: 27002630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of aberrant protein glycosylation in liver cancer plasma by AAL-enrichment and MRM mass spectrometry.
    Ahn YH; Shin PM; Kim YS; Oh NR; Ji ES; Kim KH; Lee YJ; Kim SH; Yoo JS
    Analyst; 2013 Nov; 138(21):6454-62. PubMed ID: 24027776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.